Hologic, Inc.

• A Strategic Healthcare Deal With an Expensive Price Tag

  By Anh HOANG - May 8, 2013 | Tickers: BAYRY.PK, CPTS, HOLX

  Recently, Bayer AG (NASDAQOTH: BAYRY.PK) has announced that it will acquire Conceptus (NASDAQ: CPTS) at an average of $31 per share in cash, with a total transaction value of $1.1 billion. The offering price represented a 20% premium to its trading level of $25.90 on April 26. Conceptus’ shareholders must be quite happy, as Conceptus’ share price has experienced a sweet gain of as much as 47.7 more »

• Look out Obamacare! FOR PROFIT Healthcare is the NEW Socialism

  By Adam Weissman - February 8, 2013 | Tickers: CCM, HOLX, VAR

  This article explores how a healthcare company in China is well poised to grow and thrive in a regulated environment.

• An Upbeat Investment for VNS Therapy

  By Josef Ray Dagatan - December 10, 2012 | Tickers: CYBX, HOLX, MDT, STJ

  It is the seventh consecutive quarter that Cyberonics (NASDAQ: CYBX) has reported a major increase in their income and this has been translating well for the company in terms of stock price. Yearly revenue reports from Cyberonics also project notably outstanding results with a 4-year upward trend in profits. With this excellent performance exhibited by Cyberonics in the market, and with recent developments and innovations by the company in the more »

• Are These Companies Awful or What?

  By Chris Hodge - November 14, 2012 | Tickers: LNT, EFII, FCS, HOLX

  This isn't going to be a nice article. So if you own any of the companies listed herein, I apologize for everything I'm going to say. But if I could've gone back and warned myself of some of the awful holdings I've had in the past, I would've definitely done so. Consider this tough love -- these companies are still around to the best of my more »

• Hologic's Wholly Illogical Merger

  By j.a. graham - May 7, 2012 | Tickers: GPRO, HOLX, QGEN

   

  Hologic (NASDAQ: HOLX) specializes in women’s health and operates in four business segments:

  • Breast Health   31%
  • Diagnostics     32%
  • GYN Surgical    17%
  • Skeletal Health  3%

  The company was a pioneer in digital mammography taking on the big conglomerates like GE and Siemens AG who had much larger and better-established radiology divisions. Hologic’s early growth was astronomic. 

  Part of that growth was through business mergers and acquisitions. They made six more »

• Avoid this Diagnostics Company

  By Meena Krishnamsetty - May 1, 2012 | Tickers: CPTS, GPRO, HOLX, NVS, QGEN

  This week Hologic (NASDAQ: HOLX) announced it would acquire Gen-Probe (NASDAQ: GPRO) for $3.7 billion or $82.75/share, a 20% premium based on last Friday’s close, representing ~6.0x CY 2012 revenue and ~23.0x CY 2012EBITDA, pre-synergies. The transaction financing will be all-cash and is expected to close later this year. The companies are projecting $75 million in synergies over three years, making the deal theoretically more »